Clinical trial protocol

Results: 351



#Item
151Clinical research / Pharmaceutical industry / Hepatocellular carcinoma / Clinical trial / Prostate cancer / Granulocyte macrophage colony-stimulating factor / Melanoma / Medicine / Health / Hepatology

Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities March 2013 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-04-14 16:04:09
152Gene delivery / Molecular biology / Brain tumor / Clinical trial / Design of experiments / Pharmacology / Vector / Pancreatic cancer / Cancer / Medicine / Biology / Health

First Use of a Novel Gene Transfer Agent in a Single Subject Protocol: Role of the RAC Yuman Fong, M.D. June 19, 2012

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-30 15:19:19
153Medicine / Cancer vaccine / Sirolimus / Ovarian cancer / T helper cell / Mammalian target of rapamycin / Breast cancer treatment / Biology / T cells / Immune system

Protocol I199911: A PHASE I CLINICAL TRIAL OF mTOR INHIBITION WITH SIROLIMUS FOR ENHANCING ALVAC(2)-NY-ESO1(M)/TRICOM VACCINE INDUCED ANTI-TUMOR IMMUNITY IN OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER Kunle Odu

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 11:43:35
154Drug discovery / Alkaloids / Benzoates / Docetaxel / Chemotherapy / Neuroblastoma / Clinical trial / Leukemia / Prostate cancer / Medicine / Cancer treatments / Oncology

Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities September 2012 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-11-26 15:14:05
155Science / Design of experiments / Evaluation methods / Pharmacology / Food and Drug Administration / Clinical trial / Neuroblastoma / Prostate cancer / Placebo-controlled study / Medicine / Clinical research / Research

Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting June 2005 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 12:08:12
156Pharmaceutical industry / Chemistry / Pharmacology / Design of experiments / Epidemiology / Clinical trial / Adverse event / HIV / Canadian Institutes of Health Research / Research / Clinical research / Pharmaceutical sciences

CTN_Protocol_Template_V2-02

Add to Reading List

Source URL: www.hivnet.ubc.ca

Language: English - Date: 2010-04-20 21:05:09
157Science / Scientific method / Design of experiments / Pharmacology / Food and Drug Administration / Clinical trial / Institutional review board / Case report form / Adverse event / Clinical research / Research / Pharmaceutical industry

Clinical Trial Protocol Format Title Page Includes the protocol title, product name, IND number (if applicable), author/sponsor/monitor names, investigator name/site, IRB name/address, protocol date; may also include sig

Add to Reading List

Source URL: mich.ca

Language: English - Date: 2013-08-07 10:59:02
158Science / Design of experiments / Pharmacology / Food and Drug Administration / Data / Clinical trial / Communications protocol / Pi / Clinical research / Research / Pharmaceutical industry

FAQs for the CITN U01 MEMBER SITE APPLICATION What is the due date for the Letter of Intent? The due for the LOI is October 15th as stated in the NOTICE. The due date in the CTEP site application document (Oct. 8th)

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2010-11-14 18:29:52
159Molecular genetics / Gene expression / Ribbon symbolism / Messenger RNA / Breast cancer / Biology / Genetics / RNA

mRNA CAR T Cell Pilot Trial Triple Negative Breast Cancer Protocol #[removed] “Pilot Clinical Trial of Autologous Met Redirected T cells Administered Intratumorally and Intravenously in

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 11:44:40
160Ovarian Cancer National Alliance / Medicine / Gynaecological cancer / Ovarian cancer

Protocol Title: Phase I Clinical Trial of Autologous AlphaFolate Receptor Redirected T Cells Administered Intravenously in Ovarian Cancer Patients RAC # [removed]Presentation to the Recombinant DNA Advisory Committee De

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 13:10:11
UPDATE